CV Sciences, Inc.
CVSI
$0.0414
$0.00122.99%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -8.45% | -9.90% | 2.18% | -5.48% | -0.30% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -8.45% | -9.90% | 2.18% | -5.48% | -0.30% |
Cost of Revenue | -15.19% | -9.35% | 7.19% | -7.08% | -6.85% |
Gross Profit | -0.86% | -10.52% | -3.73% | -3.53% | 8.27% |
SG&A Expenses | -1.33% | -12.23% | -12.18% | -10.27% | -20.63% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -7.91% | -22.22% | -3.42% | -8.84% | -14.11% |
Operating Income | -10.08% | 101.77% | 36.83% | 40.27% | 84.66% |
Income Before Tax | 55.31% | 83.60% | 15.72% | -2.01% | 54.55% |
Income Tax Expenses | -- | 16.67% | -55.56% | -- | -- |
Earnings from Continuing Operations | 55.31% | 82.64% | 16.46% | -2.01% | 54.66% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 55.31% | 82.64% | 16.46% | -2.01% | 54.66% |
EBIT | -10.08% | 101.77% | 36.83% | 40.27% | 84.66% |
EBITDA | -69.77% | 116.70% | 50.09% | 52.51% | 94.00% |
EPS Basic | 58.82% | 84.62% | 30.36% | 13.79% | 59.52% |
Normalized Basic EPS | -125.00% | 79.17% | 32.00% | 27.78% | 90.00% |
EPS Diluted | 58.82% | 84.62% | 31.58% | 13.79% | 59.52% |
Normalized Diluted EPS | -125.00% | 79.17% | 32.00% | 27.78% | 90.00% |
Average Basic Shares Outstanding | 6.87% | 12.99% | 17.80% | 17.89% | 12.99% |
Average Diluted Shares Outstanding | 6.87% | 12.99% | 17.80% | 17.89% | 12.99% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |